Preferential inhibition of cytoplasmic T3 binding is associated with reduced nuclear binding in cultured cells

Thyroid

Volumn 6, Issue 1, 1996, Pages 47-51

  Barlow, John W ^a,d   Raggatt, Lorna E ^a   Scholz, Gerhard H ^a,b   Loidl, Nicole M ^a   Blok, Rozanne B ^a,c   Topliss, Duncan J ^a   Stockigt, Jan R ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ST VINCENT S HOSPITAL   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DICLOFENAC; LIOTHYRONINE RECEPTOR; THYROID HORMONE;

ARTICLE; BINDING SITE; CELL DEATH; CELL STRAIN HEPG2; CELL TRANSPORT; CYTOSOL; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0030008128     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1996.6.47     Document Type: Article

References (27)

1. DeGroot LJ, Nakai A, Sakurai A, Macchia E 1989 The molecular basis of thyroid hormone action. J Endocrinol Invest 12:843-861.
2. Brent GA, Moore DD, Larsen PR 1991 Thyroid hormone regulation of gene expression. Annu Rev Physiol 53:17-35.
3. Lazar MA 1993 Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocr Rev 14:184-193.
4. Chin WW, Carr FE, Burnside J, Darling DS 1993 Thyroid hormone regulation of thyrotropin gene expression. Rec Prog Hormone Res 48:393-114.
5. Zhang X-k, Pfahl M 1993 Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. Trends Endocrinol Metab 4:156-162.
6. Yen PM, Chin WW 1994 New advances in understanding the molecular mechanisms of thyroid hormone action. Trends Endocrinol Metab 5:65-72.
7. Blondeau J-P, Osty J, Francon J 1988 Characterization of the thyroid hormone transport system of isolated hepatocytes. J Biol Chem 263:2685-2692.
8. Topliss DJ, Kolliniatis E, Barlow JW, Lim C-F, Stockigt JR 1989 Uptake of 3,4,3′-triiodothyronine by cultured rat hepatoma cells is inhibitable by nonbile acid cholephils, diphenylhydantoin, and nonsteroidal antiinflammatory drugs. Endocrinology 124:980-986.
9. Movius EG, Phyillaier MM, Robbins J 1989 Phloretin inhibits cellular uptake and nuclear receptor binding of triiodothyronine in human HepG2 hepatocarcinoma cells. Endocrinology 124:1988-1997.
10. Topliss DJ, Scholz GH, Kolliniatis E, Barlow JW, Stockigt JR 1993 Influence of calmodulin antagonist and calcium channel blockers on triiodothyronine uptake by rat hepatoma and myoblast cell lines. Metabolism 42:376-380.
11. Mooradian AD, Schwartz HL, Mariash CN, Oppenheimer JH 1985 Transcellular and transnuclear transport of 3,5,3′-triiodothyronine in isolated hepatocytes. Endocrinology 117:2449-2456.
12. Kitagawa S, Obata T, Hasumura S, Pastan I, Cheng S-Y 1987 A cellular 3,3′,5-triiodo-L-thyronine binding protein from a human carcinoma cell line. J Biol Chem 262:3903-3908.
13. Hashizume K, Miyamoto T, Ichikawa K, Yamauchi K, Kobayashi M, Sakurai A, et al. 1989 Purification and characterization of NADPH-dependent cytosolic 3,5,3′-triiodo-L-thyronine binding protein in rat kidney. J Biol Chem 264:4857-4863.
14. Fanjul AN, Parias RN 1993 Cold-sensitive cytosolic 3,5,3′-triiodo-L-thyronine-binding protein and pyruvate kinase from human erythrocytes share similar regulatory properties of hormone binding by glycolytic intermediates. J Biol Chem 268:175-179.
15. Barlow JW, Raggatt LE, Lim C-F, Kolliniatis K, Topliss DJ, Stockigt JR 1991 The thyroid hormone analogue SKF-94901 and iodothyronine binding sites in mammalian tissues: Differences in cytoplasmic binding between liver and heart. Acta Endocrinol (Copenh) 124:37-44.
16. 3 binding. Endocrinology 119:710-719.
17. Kato H, Fukuda T, Parkison C, McPhie P, Cheng S-Y 1989 Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase. Proc Natl Acad Sci USA 86:7861-7865.
18. Oppenheimer JH, Schwartz HL 1985 Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain and heart. J Clin Invest 75:147-154.
19. Lim C-F, Stockigt JR, Hennemann G 1995 Alterations in hepatocyte uptake and plasma binding of thyroxine in nonthyroidal illness and caloric deprivation. TEM 6:17-20.
20. Ashizawa K, Cheng S-Y 1992 Regulation of thyroid hormone receptor-mediated transcription by a cytosol protein. Proc Natl Acad Sci USA 89:9277-9281.
21. Stockigt JR, Lim C-F, Barlow JW, Wynne KN, Mohr VS, Topliss DJ, et al. 1985 Interaction of furosemide with serum thyroxine-binding sites: In vivo and in vitro studies and comparison with other inhibitors. J Clin Endocrinol Metab 60:1025-1031.
22. Lim C-F, Bai Y, Topliss DJ, Barlow JW, Stockigt JR 1988 Drug and fatty acid effects on serum thyroid hormone binding. J Clin Endocrinol Metab 67:682-688.
23. Munro SL, Lim C-F, Hall JG, Barlow JW, Craik DJ, Topliss DJ, et al. 1989 Drug competition for thyroxine binding to transthyretin (prealbumin): Comparison with effects on thyroxine-binding globulin. J Clin Endocrinol Metab 68:1141-1147.
24. Barlow JR, Curtis AJ, Raggatt LE, Loidl NM, Topliss DJ, Stockigt JR 1994 Drug competition for intracellular triiodothyronine-binding sites. Eur J Endocrinol 130:417-421.
25. Barlow JW, De Nayer P 1988 Characterization of thyroid hormone receptors in human IM-9 lymphocytes. Acta Endocrinol (Copenh) 117:327-332.
26. 3 and relationship to glutathione-S-transferases. Thyroid 2:39-44.
27. Lansdorp D, Janssen TJ, Guelen PJM, Vree TB 1990 High-performance liquid Chromatographic method for the determination of diclofenac and its hydroxy metabolites in human plasma and urine. J Chromatogr 528:487-494.